Ad

FTRP – Field Trip Health Ltd

Compliant

★★★★☆

Field Trip Health Ltd is Shariah compliant. The company’s financials pass four standards and fail in one.

$51,436,918

Market cap

0%

Revenue Growth

BUY

Analysts' Rating

Ad

Recommendation Rating

2.25

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 7.18

Low: 1.57

High: 11.75

Total Analysts: 3

Company Profile

Field Trip Health Ltd. is engaged in the development and delivery of psychedelic-assisted therapies (PAT). Through its Field Trip Discovery, it is engaged in developing psychedelic molecules and conducts research on plant-based psychedelics. Its Field Trip Health division operates clinics across North America and Europe providing ketamine-assisted psychotherapy (KAP) and therapies with other legal psychedelics under various programs. Its Field Trip Discovery division focuses on developing medicines targeting serotonin 5HT2A receptors. It is conducting preclinical research into its first psychedelic molecule, FT-104, targeted for treatment resistant depression (TRD) and postpartum depression (PPD). It is also exploring families of new chemical entity (NCE) structures, coined the FT-200 Group. Its Field Trip Digital division develops digital tools, such as the mobile application, Trip, and the patient application, Portal, to support and enhance patient outcomes and experience.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses